Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new serevent clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on serevent
- Study of the Effects of Different Long-Acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
Status: Recruiting, Condition Summary: Asthma - Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control
Status: Recruiting, Condition Summary: Chronic Obstructive Pulmonary Disease (COPD) - Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Recruiting, Condition Summary: Chronic Obstructive Pulmonary Disease - Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI in Patients With COPD
Status: Recruiting, Condition Summary: Chronic Obstructive Pulmonary Disease - Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD
Status: Recruiting, Condition Summary: Pulmonary Disease, Chronic Obstructive - Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg
Status: Active, not recruiting, Condition Summary: Asthma - Tiotropium and Salmeterol PK Study in COPD Patients
Status: Recruiting, Condition Summary: Pulmonary Disease, Chronic Obstructive - Comparison of Tiotropium + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPD
Status: Recruiting, Condition Summary: Pulmonary Disease, Chronic Obstructive - Safety of Exercise and High-Dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol
Status: Active, not recruiting, Condition Summary: Chronic Obstructive Pulmonary Disease - Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)
Status: Recruiting, Condition Summary: Asthma - A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg Twice Daily In Symptomatic Patients With Asthma
Status: Active, not recruiting, Condition Summary: Asthma - A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg BID In Symptomatic Subjects With Asthma
Status: Active, not recruiting, Condition Summary: Asthma - Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)
Status: Recruiting, Condition Summary: COPD - Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD
Status: Recruiting, Condition Summary: Pulmonary Disease, Chronic Obstructive - Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients
Status: Recruiting, Condition Summary: Pulmonary Disease, Chronic Obstructive - Tiotropium/Salmeterol Inhalation Powder in COPD
Status: Recruiting, Condition Summary: Pulmonary Disease, Chronic Obstructive - Tiotropium/Salmeterol Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD)
Status: Recruiting, Condition Summary: Pulmonary Disease, Chronic Obstructive - The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD
Status: Recruiting, Condition Summary: COPD - A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.
Status: Completed, Condition Summary: Pulmonary Disease, Chronic Obstructive - Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
Status: Recruiting, Condition Summary: Asthma - Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics
Status: Recruiting, Condition Summary: Asthma - Chronic Obstructive Pulmonary Disease Endpoints Study
Status: Completed, Condition Summary: Chronic Obstructive Pulmonary Disease - Influence Of Salmeterol/Fluticasone (50/500BD)On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV
Status: Not yet recruiting, Condition Summary: COPD - A Six-Week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in COPD
Status: Completed, Condition Summary: Pulmonary Disease, Chronic Obstructive - Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in COPD
Status: Completed, Condition Summary: Pulmonary Disease, Chronic Obstructive - Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).
Status: Completed, Condition Summary: Asthma; COPD - How Different Beta-2 Receptor Genotypes Affect an Asthmatic's Response to Regular Salmeterol Treatment
Status: Recruiting, Condition Summary: Asthma - Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (Study P04139AM1)(COMPLETED)
Status: Completed, Condition Summary: Asthma - Treatment Of Symptomatic Asthma In Children
Status: Recruiting, Condition Summary: Asthma - Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma
Status: Active, not recruiting, Condition Summary: Bronchial Asthma